Moderna, Inc.: Key Facts
- FY2025 revenue: $1.944B.
- FY2025 net loss: $2.822B.
- Employees: approximately 4,700 full-time employees as of December 31, 2025.
- Leadership: CEO Stephane Bancel.
- Status: public, NASDAQ: MRNA.
- Headquarters: Cambridge, Massachusetts, United States.
How Moderna Makes Money
Moderna makes money from product sales of mRNA vaccines and from collaboration, grant, and licensing revenue tied to its mRNA platform and pipeline.
Why Moderna Matters
Moderna's advantage is a reusable mRNA platform, rapid design cycle, integrated manufacturing, regulatory experience, and a pipeline that can reuse chemistry, delivery, and clinical infrastructure.
Biggest Risk
The biggest risk is that post-pandemic vaccine revenue keeps shrinking before newer respiratory, oncology, and rare-disease products become large enough to offset losses.
